Efficacy and risk factors of ultrasound-guided low-dose compound betamethasone injection on shoulder joint function in patients with rotator cuff injury
Objective To explore the effect of ultrasound-guided low-dose compound betamethasone injection on shoulder joint function in patients with rotator cuff injuries,and to analyze the factors affecting its efficacy,to provide help for clin-ical improvement of the therapeutic effect of patients with rotator cuff injury.Methods A retrospective study was con-ducted to select the clinical data of 96 patients with rotator cuff injuries who were treated in Dongyang People's Hospital from January 2022 to March 2023 as the study subjects.All patients were treated with an ultrasound-guided injection of low-dose betamethasone combined with ropivacaine.The pain level at different time points,shoulder joint function,upper limb motor ability,and daily living ability before treatment and 1 month after treatment were compared.The clinical effi-cacy of the patients was evaluated according to the Neer shoulder function score at 1 month of treatment.According to the score,the patients were divided into an excellent group and a poor group.The baseline data of patients were statistically analyzed,and binary logistic regression analysis was used to analyze the factors affecting the clinical efficacy of ultra-sound-guided low-dose hormone injection in patients with rotator cuff injury.Results After 1 month of treatment,the excellent and good rate was 80.21%(77/96)evaluated by Neer score.The Neer scores at 1 month of treatment were higher than those before treatment(P<O.05).The VAS scores at 1 hour,1 week,and 1 month after treatment were low-er than those before treatment and showed a downward trend(P<0.05).The upper limb Fugl-Meyer functional score and Barthel index score of the patients at 1 month after treatment were higher than those before treatment(P<0.05).At 1 month of treatment,the active range of motion of shoulder joint mobility was higher than that before treatment(P<0.05).The results of binary logistic regression analysis showed that age ≥ 60 years old,labor intensity of grade Ⅲ-Ⅳ,and dia-betes mellitus were risk factors affecting the clinical efficacy of patients with rotator cuff injury(OR>1,P<0.05).Conclusion Ultrasound-guided injections of low-dose betamethasone combined with ropivacaine can effectively improve shoulder joint function,upper limb movement,and daily living ability of patients with rotator cuff injuries.At the same time,age,labor intensity,and diabetes are closely related to the clinical efficacy of patients.